German Registry for Children and Adolescents with Alpha-1 Antitrypsin Deficiency (AATD).

German Registry for Children and Adolescents with Alpha-1 Antitrypsin Deficiency (AATD). - Alpha-1-KIDS-Register

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039024

Enrollment

400

Registered

2026-05-12

Start date

2024-03-01

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E88.00

Interventions

Group 1: Registry study

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Homozygous alpha-1 antitrypsin deficiency.

Exclusion criteria

Exclusion criteria: Absent of consent

Design outcomes

Primary

Measure	Time frame
Determination of the prevalence of alpha-1-antitrypsin deficiency (AATM) among children and adolescents in Germany, as well as identification of prognostic parameters for a severe disease course in childhood.	—

Secondary

Measure	Time frame
Data on recruitment & data quality, use of the digital infrastructure, and patient/family satisfaction.	—

Countries

Germany

Contacts

Public ContactRainer Ganschow

Universtätsklinikum Bonn, Zentrum für Kinderheilkunde

alpha1kinderzentrum@ukbonn.de+4922828733213

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026